These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15313853)

  • 1. Behavioral disorder, dementia, ataxia, and rigidity in a large family with TATA box-binding protein mutation.
    Bruni AC; Takahashi-Fujigasaki J; Maltecca F; Foncin JF; Servadio A; Casari G; D'Adamo P; Maletta R; Curcio SA; De Michele G; Filla A; El Hachimi KH; Duyckaerts C
    Arch Neurol; 2004 Aug; 61(8):1314-20. PubMed ID: 15313853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible reduced penetrance of expansion of 44 to 47 CAG/CAA repeats in the TATA-binding protein gene in spinocerebellar ataxia type 17.
    Oda M; Maruyama H; Komure O; Morino H; Terasawa H; Izumi Y; Imamura T; Yasuda M; Ichikawa K; Ogawa M; Matsumoto M; Kawakami H
    Arch Neurol; 2004 Feb; 61(2):209-12. PubMed ID: 14967767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CAG repeat expansion in the TATA box-binding protein gene causes autosomal dominant cerebellar ataxia.
    Fujigasaki H; Martin JJ; De Deyn PP; Camuzat A; Deffond D; Stevanin G; Dermaut B; Van Broeckhoven C; Dürr A; Brice A
    Brain; 2001 Oct; 124(Pt 10):1939-47. PubMed ID: 11571212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinocerebellar ataxia type 17 is caused by mutations in the TATA-box binding protein.
    Zühlke C; Bürk K
    Cerebellum; 2007; 6(4):300-7. PubMed ID: 17853080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focal dystonia as a presenting sign of spinocerebellar ataxia 17.
    Hagenah JM; Zühlke C; Hellenbroich Y; Heide W; Klein C
    Mov Disord; 2004 Feb; 19(2):217-20. PubMed ID: 14978680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intergenerational instability and marked anticipation in SCA-17.
    Maltecca F; Filla A; Castaldo I; Coppola G; Fragassi NA; Carella M; Bruni A; Cocozza S; Casari G; Servadio A; De Michele G
    Neurology; 2003 Nov; 61(10):1441-3. PubMed ID: 14638975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and neuropathology of autosomal dominant spinocerebellar ataxia (SCA17).
    Rolfs A; Koeppen AH; Bauer I; Bauer P; Buhlmann S; Topka H; Schöls L; Riess O
    Ann Neurol; 2003 Sep; 54(3):367-75. PubMed ID: 12953269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation analysis of the TATA box-binding protein (TBP) gene in Chinese Han patients with spinocerebellar ataxia.
    Xu Q; Li XH; Wang JL; Jiang H; Zhang S; Lei LF; Shen L; Xia K; Pan Q; Long ZG; Tang BS
    J Clin Neurosci; 2009 Oct; 16(10):1374-5. PubMed ID: 19581089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SCA17 homozygote showing Huntington's disease-like phenotype.
    Toyoshima Y; Yamada M; Onodera O; Shimohata M; Inenaga C; Fujita N; Morita M; Tsuji S; Takahashi H
    Ann Neurol; 2004 Feb; 55(2):281-6. PubMed ID: 14755733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eye movement abnormalities in spinocerebellar ataxia type 17 (SCA17).
    Hübner J; Sprenger A; Klein C; Hagenah J; Rambold H; Zühlke C; Kömpf D; Rolfs A; Kimmig H; Helmchen C
    Neurology; 2007 Sep; 69(11):1160-8. PubMed ID: 17846415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinocerebellar ataxia type 17 (SCA17): oculomotor phenotype and clinical characterization of 15 Italian patients.
    Mariotti C; Alpini D; Fancellu R; Soliveri P; Grisoli M; Ravaglia S; Lovati C; Fetoni V; Giaccone G; Castucci A; Taroni F; Gellera C; Di Donato S
    J Neurol; 2007 Nov; 254(11):1538-46. PubMed ID: 17934876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypical variability of expanded alleles in the TATA-binding protein gene. Reduced penetrance in SCA17?
    Zühlke C; Gehlken U; Hellenbroich Y; Schwinger E; Bürk K
    J Neurol; 2003 Feb; 250(2):161-3. PubMed ID: 12574945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dementia, ataxia, extrapyramidal features, and epilepsy: phenotype spectrum in two Italian families with spinocerebellar ataxia type 17.
    De Michele G; Maltecca F; Carella M; Volpe G; Orio M; De Falco A; Gombia S; Servadio A; Casari G; Filla A; Bruni A
    Neurol Sci; 2003 Oct; 24(3):166-7. PubMed ID: 14598069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinocerebellar ataxia type 17 associated with an expansion of 42 glutamine residues in TATA-box binding protein gene.
    Nolte D; Sobanski E; Wissen A; Regula JU; Lichy C; Müller U
    J Neurol Neurosurg Psychiatry; 2010 Dec; 81(12):1396-9. PubMed ID: 20587494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, genetic and neuropathological characterization of spinocerebellar ataxia type 37.
    Corral-Juan M; Serrano-Munuera C; Rábano A; Cota-González D; Segarra-Roca A; Ispierto L; Cano-Orgaz AT; Adarmes AD; Méndez-Del-Barrio C; Jesús S; Mir P; Volpini V; Alvarez-Ramo R; Sánchez I; Matilla-Dueñas A
    Brain; 2018 Jul; 141(7):1981-1997. PubMed ID: 29939198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autosomal Dominant Gene Negative Frontotemporal Dementia-Think of SCA17.
    Olszewska DA; Fallon EM; Pastores GM; Murphy K; Blanco A; Lynch T; Murphy SM
    Cerebellum; 2019 Jun; 18(3):654-658. PubMed ID: 30617627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advance in research on spinocerebellar ataxia 17].
    Zhang J; Gu W
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Feb; 31(1):44-7. PubMed ID: 24510561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinocerebellar Ataxia Type 17 (SCA17).
    Toyoshima Y; Takahashi H
    Adv Exp Med Biol; 2018; 1049():219-231. PubMed ID: 29427105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERK activation precedes Purkinje cell loss in mice with Spinocerebellar ataxia type 17.
    Lin CW; Fan CH; Chang YC; Hsieh-Li HM
    Neurosci Lett; 2020 Nov; 738():135337. PubMed ID: 32877710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complex Ataxia-Dementia Phenotype in Patients with Digenic TBP/STUB1 Spinocerebellar Ataxia.
    Nanetti L; Magri S; Fichera M; Castaldo A; Nigri A; Pinardi C; Mongelli A; Sarro L; Pareyson D; Grisoli M; Gellera C; Di Bella D; Mariotti C; Taroni F
    Mov Disord; 2023 Apr; 38(4):665-675. PubMed ID: 36799493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.